CEO Spotlight: Leadership, Innovation, & Raising Capital in a Challenging Market | LSI Europe '22
This panel will explore the innovation and capital raising paths of 4 leading innovators featured at LSI Europe.
Ofer Levy, ZygoFix - Spinal Fusion Re-Imagined | LSI Europe '22
ZygoFix develops and commercializes its zLOCK system, a proprietary technology that adds "bend-ability" to joints and provide natural stabilization. The technology is currently used to achieve spinal fusion and spinal stability without screws.
Benjamin Pless, Celero Systems - Monitoring Chronic Conditions | LSI Europe '22
The company's HEALTH-Dx platform utilizes an ingestible pill to continuously monitor cardiac and respiratory vital signs for up to a week at a time.
Edvardas Satkauskas, Sentante - Fully-Robotic Endovascular Interventions | LSI Europe '22
Sentante is developing a teleoperated/remote surgical robot for the performance of fully-robotic endovascular interventions.
Youssef Helwa, NERv Technology - Real-Time Monitoring for Anastomotic Leaks | LSI Europe '22
NERv Technology's plug-and-play technology integrates seamlessly with existing peritoneal drains and catheters to provide physicians with active patient monitoring of leakage-related surgical complications.
Jorge Presa, Cyber Surgery - Surgical Robot for Spinal Surgery | LSI Europe '22
Cyber Surgery is developing a high precision surgical robot for spinal surgery.
Joseph Rafferty, VESTECK - Endovascular Aortic Repair Grafts | LSI Europe '22
Suture-Tight catheter sutures secure endovascular aortic grafts to the aorta at the time of implant or during repair procedures.
Sebastien Ladet, Affluent Medical - Next-Gen Prostheses Developer | LSI Europe '22
Affluent Medical's cardiovascular products consist of the Kalios annuloplasty device that can be adjusted percutaneously and the Epygon, a bio-prosthesis for transapical mitral valve replacement.
Simon Sonntag, Virtonomy- Accelerating Medical Device Development & Clinical Trials | LSI Europe '22
Virtonomy has developed an end-to-end digital twin and simulation solution to perform clinical development and testing in a virtual environment to accelerate development and reduce risks, expenses, and regulatory burdens.
Todd Usen, Activ Surgical - Pioneering Digital Surgery Imaging | LSI Europe '22
Activ Surgical utilizes AI, near-infrared fluorescent imaging, and robotics to enhance surgical vizualition and navigation beyond what is visible from traditional imaging systems (e.g. endoscopy).
Ben Boyarsky, Innoventions Med - Pelvic Floor Reinforcement Device | LSI Europe '22
The PEONY device uses technology that promotes selective muscle tissue proliferation to reinforce the pelvic floor and treat pelvic floor weakness and incontinence.
Medtech Venture Investing in the Current Climate | LSI Europe '22
A lively discussion with 4 leading VCs about how the current climate is impacting (or not impacting) their investment strategies and targets.
Amos Ziv, CardiaCare - Closed-Loop Neuromodulation Device | LSI Europe '22
CardiaCare's wearable device utilizes medical grade artificial intelligence predict and deliver personalized, non-invasive electrical stimulation to the median Vagus nerve to reduce the occurrence of premature atrial contractions that are a precursor to episodes of atrial fibrillation.
Enrique Vega, Azalea Vision - Healthtech for Vision Disorders | LSI Europe '22
Azalea Vision is developing a solution for patients with conditions and disorders that increase sensitivity to light. The lens will also be capable of compensating for refractive errors of the eye, such as astigmatism and myopia.
Meron Gribetz, Inner Cosmos - Implanted Brain-Computer Interface | LSI Europe '22
Inner Cosmos' digital pill is a subcutaneously implanted brain-computer interface (BCI) to rebalance the brain.
Nitai Hanani, Paragate Medical - Implantable Peritoneal Ultrafiltration Device | LSI Europe '22
Paragate Medical is developing an implantable peritoneal ultrafiltration device that functions as a mechanical bypass too the kidneys and maintain fluid balance in patients with kidney or chronic heart failure.
Jon H. Hoem, Pacertool - Improving Cardiac Resynchronization Therapy | LSI Europe '22
Pacertools' PaCRTool provides healthcare professionals with quantifiable evidence to determine when CRT is effectively applied to heart failure patients and ensure synergy from biventricular pacing.
Mark Rosser, Serac Imaging Systems - Breakthrough Molecular Imaging Technology | LSI Europe '22
Serac's Seracam is a high-resolution hybrid gamma camera for the molecular imaging of radio-labelled tracers within the body. Seracam is designed to be a truly portable solution that can be taken outside of the nuclear medicine department and to the patient, including in outpatient clinics, physician offices, ICUs, and ORs.
Brian Thornes, X-Bolt Trauma Orthopedics - Trauma Surgery Devices | LSI Europe '22
X-Bolt develops next-generation devices for use during trauma surgeries. Key to the company's portfolio of orthopedic products are its expanding bolt design and the ability to easily reverse and remove implanted devices.
Henry Peck, Altoida - Predicting Neurological Diseases | LSI Europe '22
Altoida is using technology to predict the onset of neurlogical diseases, such as Alzheimer's disease, before symptoms occur.
Jordi Martorell, Aortyx - Aortic Dissection Treatment | LSI Europe '22
Aortyx is developing a biomimetic, bioresorbable endovascular patch that is deployed via an endovascular catheter. The patch is designed to cover an aortic tear, stop false lumen blood flow, and promote natural repair and bio-integration at the tear site.
John Wong, Fluid Biomed - Bio-Resorbable Stent for Brain Aneurysms | LSI Europe '22
Fluid Biomed is a VC-backed pre-clinical medical device start-up that has developed the world’s first bio-resorbable stent to cure brain aneurysms. Their innovative polymer technology allows physicians the versatility of treating a wider variety of aneurysms more safely and efficiently.
Abtihal Raji-Kubba, Empress Medical - Fibroid Treatment and Fertility | LSI Europe '22
The Empress system is intended to treat symptomatic uterine fibroids, in a laparoscopic procedure, by inducing fibroid tissue ischemia.
Martin Grasse, Gradient Denervation Technologies - Pulmonary Hypertension Treatment | LSI Europe '22
Gradient Denervation Technologies is using thermal ablation to reduce pulmonary pressure in patients with pulmonary hypertension. The technology will target the nerves responsible for the hyperactivity of the pulmonary artery nerves to produce a long-term reduction in pulmonary pressure.
How The Crowd, VCs & Family Offices Can Join Forces to Fund Breakthrough Medical Technologies | LSI Europe '22
This Panel was Moderated by Oscar Jofre, Co-Founder, President & CEO, KoreConX. He was joined by Panelists: Joseph McGinley, Founder & CEO, McGinley Orthopedics, Marc Giroux, CEO, Kurve Therapeutics, Peter Kassel, CEO, HealthySole, Douglas Ruark, President, Regulation D Resources, and Manny Villafana, CEO of Medical 21.
The Boardroom | LSI Europe '22
Best Practices (and Secrets) to Managing & Creating Real Value with your Board
Robotics Innovation & Investment Trends | LSI Europe '22
A discussion about innovation, investment and how the market is playing out. Hear from CEOs leading the way and investors who are in active deals.
Manny Villafana - Medical 21, Studio Interview | LSI Europe '22
CEO, Manny Villafana and Medical 21 are developing an artificial artery to eliminate the harvesting of vessels from the patient during bypass CABG surgery.
Joseph McGinley, McGinley Orthopedics - Studio Interview | LSI Europe '22
McGinley Orthopedics have developed the IntelliSense Drill, an innovative handheld robotic technology which can change the standard of care in orthopedic procedures.